LMG Life Sciences Awards EMEA 2023: winners revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

LMG Life Sciences Awards EMEA 2023: winners revealed

LMG Life Sciences Awards EMEA 2023 logo

4th annual awards announces winners

On July 13th 2023, we were thrilled to host the LMG Life Sciences Awards gala celebration at the Waldorf Hilton - London, with guests joining us from across the EMEA region.

The gala cermeony saw the culmination of months of research into the leading life sciences attorneys and law firms, having draw upon submissions, client feedback, and detailed research from throughout the region. These awards aim to recognise complex and impactful work across an array of legal specialisms that operate within the life sciences industry. The LMG Life Sciences team would like to express theri deepest gratitude to every firm, lawyer, and company that participated in the research for this year's awards.

A big congratulations to all of this year's winners and the shortlisted nominees!

A few of our 2023 winners are:

LMG Life Sciences Awards EMEA 2023 logo

Bird & Bird

Patent Litigation: Medical Devices Firm of the Year

LMG Life Sciences Awards EMEA 2023 logo

Jennifer Antcliff

Carpmaels & Ransford

SPC Litigator of the Year

LMG Life Sciences Awards EMEA 2023 logo

Tess Waldron

Powell Gilbert

IP Rising Star

The full list of winners can be found on the LMG Life Sciences website via the link below.

And the winners are ...

LMG Life Sciences is a sister publication to and supported by Managing IP, whose research is ran independently from IP Stars research.

more from across site and SHARED ros bottom lb

More from across our site

François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Gift this article